MedPath
NMPA Approval

Cefadroxil for Suspension

国药准字H20233852

June 30, 2023

Drug Information

头孢羟氨苄干混悬剂

口服混悬剂

2.5g(250mg/5ml)(按C₁₆H₁₇N₃O₅S计 )

化学药品

June 30, 2023

Company Information

Applicant Company

上海市金山工业区揽工路958号

Manufacturing Company

上海市金山工业区揽工路958号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

头孢羟氨苄干混悬剂 - NMPA 批准文号 | MedPath